Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
Holding SIBN?
Track your performance easily
Earnings Data
Report Date
Mar 03, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.27Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 07, 2019
|% Change Since: 6.78%
|Next Earnings Date:Nov 29, 2018
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and profitability improvements, driven by new product launches and increased physician engagement. Despite challenges like Hurricane Helene and scheduling issues, the company remains optimistic about future growth.Company Guidance
During the third quarter of 2024, SI-BONE reported record worldwide revenue of $40.3 million, marking a 19% growth, with U.S. revenue increasing by 18% to $38.3 million. The company achieved nearly breakeven adjusted EBITDA, using only $700,000 in cash for the quarter. The growth was driven by a 21% increase in trailing 12-month revenue per territory to $1.8 million, with expectations to surpass $2 million. The active physician base grew by nearly 150 to over 1,200, with a 35% increase in physicians performing multiple procedure types and a 25% increase in procedure volume among physicians active in both Q3 2024 and Q3 2023. The company also highlighted the 510(k) clearance for iFuse-TORQ TNT, expected to tap into the $300 million pelvic trauma market. SI-BONE anticipates worldwide revenue for 2024 to be between $165 million and $166 million, with fourth quarter adjusted EBITDA expected to be positive.Record Worldwide Revenue
SI-BONE delivered worldwide revenue of $40.3 million, reflecting 19% growth, marking a record revenue quarter.
Significant Increase in Active Physicians
Ended the quarter with over 1,200 active physicians, an increase of nearly 150 physicians year-over-year.
Launch of New Products
Received 510(k) clearance for iFuse-TORQ TNT, a second breakthrough device in 2 years, expanding presence in the trauma market.
Improvement in Profitability
Net loss improved by 34% to $6.6 million, and adjusted EBITDA loss was $200,000, reflecting a 94% improvement.
Strong Balance Sheet
Exited the quarter with nearly $151 million in cash and marketable securities, with quarterly cash usage of only $700,000.
---
SIBN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SIBN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $15.63 | $13.14 | -15.93% |
| Aug 05, 2024 | $14.04 | $14.22 | +1.28% |
| May 06, 2024 | $14.48 | $15.68 | +8.29% |
| Feb 26, 2024 | $20.54 | $17.76 | -13.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does SI-Bone Inc (SIBN) report earnings?
SI-Bone Inc (SIBN) is schdueled to report earning on Mar 03, 2025, TBA Not Confirmed.
What is SI-Bone Inc (SIBN) earnings time?
SI-Bone Inc (SIBN) earnings time is at Mar 03, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SIBN EPS forecast?
SIBN EPS forecast for the fiscal quarter 2024 (Q4) is -0.15.
---